- Home
- TMUS vs ABBV Comparison
TMUS vs ABBV Comparison
Compare TMUS & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- ABBV
- Stock Information
- Founded
- TMUS 1994
- ABBV 2012
- Country
- TMUS United States
- ABBV United States
- Employees
- TMUS N/A
- ABBV N/A
- Industry
- TMUS Telecommunications Equipment
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- TMUS Telecommunications
- ABBV Health Care
- Exchange
- TMUS Nasdaq
- ABBV Nasdaq
- Market Cap
- TMUS 276.5B
- ABBV 303.1B
- IPO Year
- TMUS N/A
- ABBV N/A
- Fundamental
- Price
- TMUS $220.31
- ABBV $175.62
- Analyst Decision
- TMUS Strong Buy
- ABBV Strong Buy
- Analyst Count
- TMUS 21
- ABBV 22
- Target Price
- TMUS $239.65
- ABBV $207.45
- AVG Volume (30 Days)
- TMUS 4.2M
- ABBV 6.8M
- Earning Date
- TMUS 01-23-2025
- ABBV 01-31-2025
- Dividend Yield
- TMUS 1.60%
- ABBV 3.74%
- EPS Growth
- TMUS 36.23
- ABBV N/A
- EPS
- TMUS 8.76
- ABBV 2.87
- Revenue
- TMUS $80,006,000,000.00
- ABBV $55,533,000,000.00
- Revenue This Year
- TMUS $5.08
- ABBV $5.28
- Revenue Next Year
- TMUS $4.84
- ABBV $5.73
- P/E Ratio
- TMUS $25.16
- ABBV $61.18
- Revenue Growth
- TMUS 2.11
- ABBV 0.72
- 52 Week Low
- TMUS $153.84
- ABBV $153.09
- 52 Week High
- TMUS $248.15
- ABBV $207.32
- Technical
- Relative Strength Index (RSI)
- TMUS 34.78
- ABBV 47.03
- Support Level
- TMUS $217.79
- ABBV $170.34
- Resistance Level
- TMUS $233.33
- ABBV $178.13
- Average True Range (ATR)
- TMUS 4.85
- ABBV 3.59
- MACD
- TMUS -2.90
- ABBV 0.26
- Stochastic Oscillator
- TMUS 8.89
- ABBV 40.68
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the us. T-Mobile now serves 77 million postpaid and 21 million prepaid phone customers, equal to around 30% of the us retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves more than 5 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).